Eiger BioPharmaceuticals

December 10, 2020

Gilead goes back to basics with €1.2bn MYR acquisition

December 02, 2020

US FDA approval tracker: November

October 30, 2020

Go or no go? Big decisions loom for Bristol and Sanofi

The FDA will have a busy November, with decisions due for Bristol, Sanofi and Y-mabs, among others.

January 17, 2018

Avalanche on Eiger as repurposed inflammation drug fails

April 10, 2017

EASL – Other hepatitis viruses take the spotlight along with Nash

March 13, 2015

J&J re-homes cancer project with Kura